Shareholding disclosure

Novartis AG

Declared position

6.41%

Threshold

Crossed upwards

Timeline

Published

30.10.2020

Transaction

27.10.2020

Voting rights breakdown

Voting rights acquired6.41%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAKAT00020

Beneficial owner

Novartis AG

Declared address

Novartis AG, Basel

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Novartis AG

Molecular Partners AG30.10.2020TAKAT00020

Disclosure summary

Novartis AG disclosed a holding in Molecular Partners AG on the acquisition side, published by SIX Exchange Regulation on 30.10.2020, at 6.41% of voting rights. Notice category: Single shareholder.

Disclosed position

6.41%

Voting rights acquired

Voting rights acquired6.41%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Novartis AG disclosed a holding in Molecular Partners AG, published on 30.10.2020.

Publication date30.10.2020

Transaction date27.10.2020

Issuing companyMolecular Partners AG

Beneficial ownerNovartis AG

Declared addressNovartis AG, Basel

CategorySingle shareholder

Voting rights acquired6.41%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAKAT00020

Commercial register

CHE-103.867.266

Registered

Zefix record

Source: SIX Exchange Regulation · Publication date: 30.10.2020

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open